Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Enanta Pharmaceuticals |
365.48 Mn |
201.71 Mn |
- |
44.17% |
| Date | Value |
|---|
| Mar 31, 2026 |
44.17% |
| Dec 31, 2025 |
58.10% |
| Sep 30, 2025 |
78.98% |
| Jun 30, 2025 |
99.84% |
| Mar 31, 2025 |
98.35% |
| Dec 31, 2024 |
90.15% |
| Sep 30, 2024 |
76.52% |
| Jun 30, 2024 |
55.89% |
| Mar 31, 2024 |
30.05% |
| Dec 31, 2023 |
15.88% |
| Sep 30, 2023 |
11.51% |
| Jun 30, 2023 |
8.97% |
| Mar 31, 2023 |
4.30% |
| Dec 31, 2022 |
-5.86% |
| Sep 30, 2022 |
-17.33% |
| Jun 30, 2022 |
-26.11% |
| Mar 31, 2022 |
-25.14% |
| Dec 31, 2021 |
-16.96% |
| Sep 30, 2021 |
-10.80% |
| Jun 30, 2021 |
-7.60% |
